Introduction: The antibodies have an important role in the serodiagnosis, constituting the most widely used biomarkers to detect and confirm various diseases. Objective: To investigate the reproducibility of anti-human immunodeficiency virus (HIV) antibodies reactivity, to assess the stability of the sera samples stored at -20ºC for two to eighteen years. Method: Sera were collected in the period 1988-2004 for routine anti-HIV antibodies diagnostic testing. The remaining samples stored at -20ºC, were analyzed in this study. Serum sample stability was assessed by enzyme-linked immunosorbent assay/enzyme immunoassay (ELISA/EIA), indirect immunofluorescence assay (IFA), and Western blot (WB) for detecting anti-HIV antibodies. The previously found results (1988)(1989)(1990)(1991)(1992)(1993)(1994)(1995)(1996)(1997)(1998)(1999)(2000)(2001)(2002)(2003)(2004) and those obtained in 2006 were subjected to Kappa index analysis. Result: In the period 1988-to 2004, the degree of concordance of the ELISA/EIA, IFA and WB results were considered, good (k = 0.80), regular (k = 0.35), and good (k = 0.63), respectively. Conclusion: Regarding HIV serologic test, the serum samples were stable for 18 years in ELISA/EIA and for 4 years in IFA technique, however, for the WB methodology it was not possible to determine the time of stability of the anti-HIV antibodies.
Laboratory tests to diagnose infection with the human immunodeficiency virus (HIV) have been used for three decades and, up to now, they are still an important tool in the diagnosis and the quality of blood evaluation in haemotherapy units (7) . Therefore, the results of serological tests must be accurate and be correctly taken, because the medical and social importance of a positive HIV test (5) .
The enzyme immunoassay (ELISA/EIA) technique has been worldwide used as initial serological screening for detection of anti-HIV antibodies, and the samples with positive reactivity in these tests have been confirmed by Western blot (WB) and indirect immunofluorescence (IFI) techniques (14) .
The antibodies have an essential role in serodiagnosis and represent the most widespread biomarkers used for detection and confirmation of various diseases. Given its specific affinity for the antigen, the integrity of the three-dimensional chemical structure of these molecules is crucial for this interaction. Structural changes or molecular aggregation, depending on storage conditions, lead to a decrease in the antibodies activity, which may lead to false negative results (17) .
The degradation of stored biological material is an important factor to be investigated. When the samples are retested after stored for long time, this evaluation became complex. When results were not reproduced, it is difficult to verify if material degradation occurred in fact, or if the difference is results is due to the use of more sensitive laboratory tests developed over time (18) . For many years, the excess of material of biological specimens collected to perform diagnostic procedures has been stored, in order to confirm a diagnosis later or for potential use in future research (16) . In this context, the maintenance of serum sample stored frozen and held for future studies has been extremely First submission on 21/10/13; last submission on 10/07/14; accepted for publication on 12/07/14; published on 20/08/14 1 useful in assessing the transmission of various pathogens. Moreover, the availability of viable stored material enables making inquiries about health problems in the past, with the use of current and advanced technological resources. Some of the benefits resulting from the use of stored biological samples in research proved to be of great social relevance (11) .
The access to biological materials of biobanks associated with detailed clinical information are of inestimable value, not only for research purposes but also in field service, with obvious benefits to society (2) . Thus, a quality management plan, with the appropriate standard operating procedure, is essential in technical operations involving biospecimens (19) . Stability studies on biomolecules stored for long periods under controlled conditions are rare and restricted to a limited number of proteins and analytes (8) . Due to scarcity of available data on which adverse effect the long-term storage may cause in the antibodies configuration, protein structures that are inclined to denaturation, it is particularly relevant to conduct a research through implementation of sensitive and specific assays. The concern with the storage time of the serum is related to various factors, such as temperature and samples freezing and thawing processes, which may cause occasional changes in the results of a particular test due to physical decay and, consequently, the biochemical modifications of antibodies of interest (3, 4, 9, 10, 15) .
oBJECtivE
With the availability of serum samples with known reactivity regarding the anti-HIV antibodies and because the lack of an established norm in relation to the storage time of clinical and biological samples, this retrospective study was proposed to investigate the stability of sera stored for periods of two to eighteen years. The stability of specific antibodies was evaluated by the reproducibility of anti-HIV results, using sensitive and specific assays used in the routine of Laboratory of the Center of Immunology at Instituto Adolfo Lutz (IAL), São Paulo-SP, Brazil.
MEthoD
The study was approved by the Human Research Ethics Committee-IAL (document nº 017/2011).
The sera used were from the remaining samples of routine diagnostic detection for anti-HIV antibodies, for the period 1988-2004, which were stored and frozen at -20ºC in the Laboratory of HIV/Aids of the Center of Immunology-IAL.
Aspects relating to confidentiality and privacy of clinical and laboratorial information and patients identification were considered essential, so we used the not linked anonymous study. Serological tests performed in serum samples, stored for this retrospective study, did not diverge from the scope in which they were intended, i.e., detection of anti-HIV antibodies.
In this retrospective study, serum samples stores during the period 1988-2004 were analyzed in 2006. The selection criteria to establish the number of serum samples (n = 1,000) was according to availability of laboratory reagents, which were intended for routine diagnosis. The selection of samples to perform the proposed evaluation was performed randomly, using the Microsoft Office Excel tools (Microsoft Corp., Redmont, WA, USA).
In 2006, to perform stability analysis of the sera by ELISA/EIA reproducibility of results were grouped by length of storage time, in order to ascertain the presence of adverse effects on serum over the years. Groups were set/established so that the number of samples in each block was higher than 100, as following described According to the criteria established in this study, the number of serum samples analyzed in WB test was much lower than those in ELISA/EIA and IFI methodologies. Thus, to evaluate the reproducibility of the results, we adopted the recommendation of the International Organization for Standardization/Technical report (ISO/TR) 14468/2010 (13) , where sera were divided in groups of, at least, 20 samples per time period. Thus, two groups were formed: 1988-1997 and 1998-2004, with 26 sera in each.
Serum samples were initially subjected to ELISA/EIA (Vironostika HIV Uni-Form Plus O (Biomérieux SA, France) or Murex HIV 1.2.O (Abbott Diagnostics, United Kingdom). Results were considered as reactive, non-reactive, and indeterminate, according to test reactivity threshold or cut-off, according to calculations determined by manufacturers of each set of diagnostic reagents used.
IFI tests (IFI-HIV-1 [BioManguinhos-Fundação Oswaldo
Cruz {FIOCRUZ}], Brazil) and WB tests (HIV blot 2.2 [Genelabs Diagnostics], Singapore) were used as confirmatory, and results were expressed as positive, negative, and indeterminate, in compliance with the reactivity patterns recommended by manufacturers of the respective reagents.
The reactive or indeterminate results in ELISA/EIA were initially evaluated by IFI-HIV-technique, and whether indeterminate or negative results, they were analyzed by WB.
The diagnostic reagents sets underwent evaluation procedures through commercial seroconversion and performance panels (Boston Biomedica, Inc -Cambridge, MA, USA).
Statistical analysis
Results were analyzed in Microsoft Office Excel (Microsoft Corp., Redmont, WA, USA) and STATISTICA software (version 11 Tulsa, OK, USA).
The agreement between results of HIV tests performed in 1988-2004 and in 2006 was assessed using kappa statistics (Cohen, 1960 ) (6) , according to the period of time established for each technique used.
The interpretation of agreement levels, according to kappa values (k), was performed based on the method proposed by Altman (1999) (1) , adapted to Landis and Koch (1977), which k < 0.20 value represents poor reproducibility; 0.21-0.40 regular; 0.41-0.60 moderate; 0.61-0.80 good; and 0.81-1.00 very good agreement.
rESuLtS From 1.000 randomly selected samples, 155 (15.5%) sera could not be included in the study for the following reasons: sample was not found, insufficient volume of sample, or sample with gelatinous aspect. The 845 serum samples that could be evaluated showed, in its first analysis, the following results: 376 (44.5%) HIV non-reactive, 431 (51%) HIV reactive, and 38 (4.5%) indeterminate samples.
In the evaluation performed in 2006, from 845 samples that were subjected to ELISA/EIA, 385 (45.6%) showed non-reactive, 425 (50.3%) reactive, and 35 (4.1%) indeterminate results. Following the criteria described in this study methodology, sera with negative (n = 28) and indeterminate (n = 73) results in IFI assay would be analyzed in WB. However, from 101 sera, 49 (48.5%) were not evaluated for reproducibility because they had not been previously analyzed by WB technique; the remaining 52 sera (51.5%) showed the following results in this assay: two (3.8%) negative, 20 (38.5%) positive, and 30 (57.7%) indeterminate.
Data concerning sample reproducibility in each methodology are shown in Table 1 . It is observed that, according to the criteria established for interpretation of index k, the degree of agreement to ELISA/EIA − period 1988-2004 −, therefore referring to 18 years of storage at -20ºC, was considered good, and about 90% of agreement was observed. If stricter evaluation criteria were used for this methodology, we consider only the periods when index k value was equal or greater than 0.8 and, thus, ensuring the highest level of sera stability, the optimal storage time to detect anti-HIV antibodies was 12 years (i.e., after 1994), with about 93% of agreement average observed. 
DiSCuSSion
Conducting this work was of great importance, due to scarcity of data available in the literature, and numerous inquires received by researches and specialized technicians, working in the HIV/Aids area in several research and teaching institutions, regarding the reactivity and durability of serum antibodies produced against different pathogens, particularly HIV. Although this study did not performed measurement of immunoglobulins (15) and avidity tests for analyzed samples,
index k values detected showed that depending on the methodology used, the storage time of serum sample affects the anti-HIV antibodies detection.
In this study, it was observed that samples showed reproducible results for 18 years in ELISA/EIA methodology, and for four years in IFI technique. However, during analysis of results reproducibility in WB methodology, it was not feasible to determine the stability time of sera, due to index kappa value (k = 0.52) obtained in the two established periods. Even following the criteria recommended by ISO/TR 14468 (13) , i.e., preparing groups of at least 20 samples for each time period, when sera were subdivided into two periods (1988-1997 and 1998-2004) , the index kappa was only moderate. Perhaps, this change occurred because of the small number of samples in each period, and may not necessarily be a reflection of the reproducibility of these 52 samples in the period of 1988-2004, when there was a significant increase in index k value. Thus, this evaluation was impaired by the inability to determine the exact period of stability for WB. It is necessary, in further studies, to evaluate a larger number of samples in order to establish a more accurate period of time.
In 61 serum samples (21.3%), with previously positive results by IFI, it was found that positivity was not kept, when evaluated in 2006. Confirmatory tests are designed to achieve more specificity and loss of serum stability may produce false negative results, since sensitivity is generally lower than screening tests. Results reproducibility of laboratory assays is critical, whether in research or diagnostic laboratories. Given this, it is recommended that the researcher have knowledge about the influence of long-term storage of the antibody of interest in serum sample and the type of assay used.
Other cares are fully advisable, such as planning the biological sample storage in ideal conditions, allowing the use of the material in future investigations. Since the moment of the material collection, it is necessary to define necessary to define the sampling, transport, and storage procedures, as well as monitoring equipments to ensure sample integrity. Strict control of these conditions provides an added value to the samples, allowing to ensure quality, traceability, and reproducibility of results (16) . Although constant monitoring of storage equipments are part of quality control management at IAL, we detected fungal contamination in some serum analyzed in this investigation by IFI technique, which reveals evidence of irregular storage of these samples. Regarding to pre-analytical stage, the process control was not feasible due to the blood collection had been performed in different healthcare units.
More and more, there is a demand in actualize systems that ensure the quality of sera, such as the implementation of institutional biobanks. Quality control of stored biological materials is a prerequisite for the success of research studies, since it constitutes an important indicative parameter of sample degree of conservation and, thereby, ensuring the results reproducibility.
According to Gislefoss (2010) studies (12) , storage conditions may be crucial for the quality of the samples. When this happens, the robustness of analytical methods may change regarding sample variations and, therefore, component instability may invalidate the results of investigation. This data confirms that the knowledge on the stability of sera stored at -20ºC for long periods is essential to maintain the good quality of a serum bank, and to meet the demands of service provision requirements and to achieve reliable results in different laboratory tests, for research or assistance purposes.
In addition to concerns with the extension of storage process of biological materials, many researchers (4, 9, 15) are interested in checking the effect of multiple consecutive cycles of freezing and thawing on antibody reactivity, since this procedure may cause occasional change in results of a particular test. In this study it was not possible to have evidence of the number of freezing and thawing cycles of analyzed samples, but the relevance of this aspect may be decreased, as found in Castejon et al. (2012) study (4) , which did not observed adverse effects on the reactivity of positive samples for detection of anti-HIV antibodies, without false-negative occurrence reaction, either false-positive results in negative samples for HIV, after multiple cycles of sera freezing and thawing.
In this context there are several parameters that must be taken into account to ensure the stability of the sera. Among them, as described by Souza (2012) (17) , there is evidence that the sample volume must not be lower than 10 µl during serum storage once this may interfere with the results of reactions, since the evaporation process and antibodies adsorption on the surface of the storage vial modify sample concentrations. The IAL study was outlined to select samples with enough volume (minimum 150 µl) to perform the serological tests, therefore, samples with low volume were not part of the scope of this work.
The pre-analytical process, the mechanisms of sample degradation during storage, and the analytical methodologies used are factors directly associated with the quality of the serum samples. Thus, the combined knowledge on stability of component, the appropriate study design, and the choice of test methodology are essential for understanding the limitations which may occur, when using these samples for future studies.
According to the methodology of serological tests used, the storage time of serum sample interfered with the stability of detected anti-HIV antibodies. Kappa values show that serum samples stored for 18 years, when analyzed in ELISA/EIA methodologies, showed good reproducibility of the results, however, when evaluated in the IFI assay, a significant drop was observed in this index, and the reproducibility was classified as regular.
ConCLuSion
The present study showed that in relation to HIV tests, the serum samples were stable for 18 years in ELISA/EIA, and for four years with IFI technique. However, it was not possible to determine the time stability of the samples with WB methodology.
ACknowLEDgEMEntS
For André R. de Campos and Maria C. Sartorato, from Center of Immunology of IAL, for technical support in conducting this study. 
